CD19 MONOCLONAL-ANTIBODY HD37 INHIBITS ANTI-IMMUNOGLOBULIN-INDUCED B-CELL ACTIVATION AND PROLIFERATION

被引：0
|
作者：
PEZZUTTO, A
DORKEN, B
RABINOVITCH, PS
LEDBETTER, JA
MOLDENHAUER, G
CLARK, EA
机构：
[1] UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT MICROBIOL & IMMUNOL, SEATTLE, WA 98195 USA
[3] UNIV WASHINGTON, REG PRIMATE RES CTR, SEATTLE, WA 98195 USA
[4] GERMAN CANC RES CTR, INST IMMUNOL & GENET, D-6900 HEIDELBERG 1, GERMANY
[5] ONCOGEN CORP, SEATTLE, WA 98121 USA
来源：
JOURNAL OF IMMUNOLOGY | 1987年 / 138卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2793 / 2799
页数：7
相关论文
共 50 条
  • [1] DIFFERENTIAL-EFFECTS OF ANTI-CD45 MONOCLONAL-ANTIBODY ON HUMAN B-CELL PROLIFERATION - A MONOCLONAL-ANTIBODY RECOGNIZING A NEURAMINIDASE-SENSITIVE EPITOPE OF THE T200 MOLECULE ENHANCES ANTI-IMMUNOGLOBULIN-INDUCED PROLIFERATION
    ALSINET, E
    INGLESESTEVE, J
    VILELLA, R
    LOZANO, F
    MILA, J
    ROJO, I
    MARTORELL, J
    VIVES, J
    GAYA, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (12) : 2801 - 2804
  • [2] ROLE OF INTERLEUKIN-1 IN ANTI-IMMUNOGLOBULIN-INDUCED B-CELL PROLIFERATION
    HOWARD, M
    MIZEL, SB
    LACHMAN, L
    ANSEL, J
    JOHNSON, B
    PAUL, WE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (05): : 1529 - 1543
  • [3] A MONOCLONAL-ANTIBODY TO A B-CELL ACTIVATION ANTIGEN (HC2) INHIBITS B-CELL STIMULATORY FACTOR-INDUCED PROLIFERATION
    POSNETT, DN
    CHLORAZZI, N
    WANG, CY
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A386 - A386
  • [4] EFFECT OF K+ CHANNEL BLOCKERS ON ANTI-IMMUNOGLOBULIN-INDUCED MURINE B-CELL PROLIFERATION
    GOLLAPUDI, SVS
    VAYUVEGULA, BS
    THADEPALLI, H
    GUPTA, S
    [J]. JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1988, 27 (03) : 121 - 125
  • [5] Tafasitamab Monoclonal antibody targeting CD19 Treatment of B-cell malignancies
    Narkhede, M.
    Cheson, B. D.
    [J]. DRUGS OF THE FUTURE, 2020, 45 (09) : 641 - 651
  • [6] ENHANCEMENT OF HUMAN B-CELL PROLIFERATION BY A MONOCLONAL-ANTIBODY TO CD43
    WIKEN, M
    BJORCK, P
    AXELSSON, B
    PERLMANN, P
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (03) : 363 - 370
  • [7] CONTROL OF B-CELL PROLIFERATION BY CD19 MCAB
    SHIELDS, JG
    SMITH, SH
    CALLARD, RE
    [J]. LYMPHOKINE RESEARCH, 1988, 7 (03): : 306 - 306
  • [8] INITIAL EXPERIENCE WITH TREATMENT OF HUMAN B-CELL LYMPHOMA WITH ANTI-CD19 MONOCLONAL-ANTIBODY
    HEKMAN, A
    HONSELAAR, A
    VUIST, WMJ
    SEIN, JJ
    RODENHUIS, S
    HUININK, WWT
    SOMERS, R
    RUMKE, P
    MELIEF, CJM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 32 (06) : 364 - 372
  • [9] Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
    Hatterer, Eric
    Barba, Leticia
    Noraz, Nelly
    Daubeuf, Bruno
    Aubry-Lachainaye, Jean-Pierre
    von der Weid, Benoit
    Richard, Francoise
    Kosco-Vilbois, Marie
    Ferlin, Walter
    Shang, Limin
    Buatois, Vanessa
    [J]. MABS, 2019, 11 (02) : 322 - 334
  • [10] INDUCTION OF B-CELL PROLIFERATION BY LY-5 MONOCLONAL-ANTIBODY
    YAKURA, H
    KAWABATA, I
    SHEN, FW
    KATAGIRI, M
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (01) : 181 - 181
12345